Oxford Nanopore Technologies, the global leader in nanopore sequencing, went public on the London Stock Exchange, making the number of SCGC's listing cases increased to 196

Oxford Nanopore Technologies, the global leader in nanopore sequencing, went public on the London Stock Exchange, making the number of SCGC's listing cases increased to 196.

On 30 Sep. 2021, Oxford Nanopore Technologies (hereinafter referred to as "ONT", stock code: ONT. L), the world's leading nanopore sequencing Unicorn company, went public on the London Stock Exchange and became the 196th listing case of SCGC. It is also SCGC's first listing case in the UK.

ONT originated from the University of Oxford and was established in 2005. Now it has developed into one of the global unicorns in the field of in vitro diagnosis.

SCGC invested in ONT through its wholly-owned overseas subsidiaries in 2018, achieving a breakthrough of zero investment projects in the UK. After the investment, the project team conducted continuous discussions with ONT on the docking of domestic resources as well as medium and long-term development. Internationalization is one of the development strategies of SCGC. In the future, SCGC will continue to strengthen international exchanges, cooperate with institutional partners and excellent enterprises in various countries for win-win results, jointly promote global scientific and technological progress, and build bridges to help more excellent Chinese enterprises "go global" and more excellent foreign enterprises "come in".